NU 7441
Tocris Bioscience | Catalog # 3712
Key Product Details
Description
Alternative Names
Product Description
NU 7441 is a potent and selective DNA-PK inhibitor (IC50 = 14 nM). Selective for DNA-PK over a range of kinases including mTOR, PI 3-K, ATM and ATR. Potentiates the effects of doxorubicin (Cat. No. 2252) and etoposide (Cat. No. 1226) in vitro and etoposide in vivo. Also enhances CRISPR-Cas9-mediated homology-directed repair (HDR) efficiency 2 to 3-fold, and decreases nonhomologous end-joining (NHEJ) frequency ~40%.
Product Specifications for NU 7441
Molecular Weight
Formula
Storage
Purity
Chemical Name
CAS Number
PubChem ID
InChI Key
SMILES
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Solubility
| Solvent | Max Conc. mg/mL | Max Conc. mM | |
|---|---|---|---|
| Solubility | |||
| DMSO | 2.07 | 5 with gentle warming |
Preparing Stock Solutions for NU 7441
The following data is based on the product molecular weight 413.49.
Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which all affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.05 mM | 48.37 mL | 241.84 mL | 483.69 mL |
| 0.25 mM | 9.67 mL | 48.37 mL | 96.74 mL |
| 0.5 mM | 4.84 mL | 24.18 mL | 48.37 mL |
| 2.5 mM | 0.97 mL | 4.84 mL | 9.67 mL |
Calculators
Background References
References are publications that support the biological activity of the product. See our Citations tab to view 203 publications citing the usage of this product.
- Robert Pharmacological inhibition of DNA-PK stimulates Cas9-mediated genome editing. Genome Med. 2015 PMID: 26307031
- Willmore DNA-dependent protein kinase is a therapeutic target and an indicator of poor prognosis in B-cell chronic lymphocytic leukemia. Clin.Cancer Res. 2008 PMID: 18559621
- Leahy Identification of a highly potent and selective DNA-dependent protein kinase (DNA-PK) inhibitor (NU7441) by screening of chromenone libraries. Bioorg.Med.Chem.Lett. 2004 PMID: 15546735
- Zhao Preclinical evaluation of a potent novel DNA-dependent protein kinase inhibitor NU7441. Cancer Res. 2006 PMID: 16707462
Product Documents for NU 7441
Certificate of Analysis
To download a Certificate of Analysis, please enter a lot or batch number in the search box below.
Product Specific Notices for NU 7441
For research use only
Related Research Areas
Citations for NU 7441
Customer Reviews for NU 7441 (1)
Have you used NU 7441?
Submit a review and receive an Amazon gift card!
$25/€18/£15/$25CAN/¥2500 Yen for a review with an image
$10/€7/£6/$10CAN/¥1110 Yen for a review without an image
Submit a review
Customer Images
-
Species: HumanAssay Type: In VitroCell Line/Tissue: helaVerified Customer | Posted 02/29/2020HeLa cells transfected with in vitro transcribed I-PpoI and treated or not with inhibitors for KU 55933 and NU 7441 (iDPK)
There are no reviews that match your criteria.